If you followed my prior videos you bought this trade early in this cycle. I still think some strategic moves are in play. In either case plan to hold through $8 and evaluate the technical situation then.
Last day or two to get this before the next leg starts. That will be the most valuable leg.
I know this space. In my opinion VRM is ready to rally. If you believe in parity Carvana should be cheaper and Vroom should be more valuable. Related symbol of interest is SFT (Shift Technologies) I think either VRM or CVNA could end up buying shift. That said Vroom is a lot bigger and I like the stock set-up for a nice rip.
This is a development stage bio-tech company. Not planning to hold long term but should give a great short term gain.
In this video I explain my trade thesis on Go health Inc. We are in an option short strangle and the stock is going to smash north after Friday's expiration date.
I had previously said that the raise they did was for something major or strategic. I still believe that and expect some announcement will be coming.
This stock is currently 99.8% institutionally held. The squeeze can push it up to $20+ pretty easy.
I previously published an idea on $GOCO on 12/10/20 and so far the trade is going exactly as I expected. More upside here.
This is a purely technical set-up. I am thinking short term it can hit and test the $5 market.
This is purely a technical analysis play. I like the movement here and I think short term upside is as high as $14.50
Progenity is doing what I expected up over 10% today. Once it goes north of $4.05 it should quickly work its way to $5.21 and if it holds $5.21 all the way to $8.
Technical trade. This had consolidated down and now under accumulation I think you will see a nice push into the $16's and possibly even higher in the short run.
I like the set-up here for a continuation rally that can push $BTU to $2.50+
Here is my latest analysis of Progenity, Inc. Possible that Illumina Inc or Johnson and Johnson would want to buy this to protect their portfolio of pre-natal testing products? In either case it could play out.
I posted this idea a couple of days ago. After hours on Friday news came out via an S-4 filing with the SEC that CEO Harry Stylli bought 152,905 shares of PROG stock on the open market. He currently owns 14,616,874 shares in total.
News came out that a secondary was taking place @ fair value for this stock which is quite beat up. With an option to buy an additional 1.146 million shares at $3.27. This is extremely bullish for the short term prospects on this stock.
Even with the earnings ALGN put up there valuation is extremely stretched. I don't think there will be a ton of net buying to sustain this price point and therefore I believe the risk reward favors a short.
Institutional investors may have been selling and shorting Energy Transfer. Their mistake can make you a great return quickly. The dividend has been confirmed providing a massive yield The tax treatment of domestic energy limited partnerships can provide a massive benefit This stock is extremely under valued